POEM of the Week Podcast

Each week Dr. Mark Ebell, POEMs Editor, joins Dr. Michael Wilkes, NPR correspondent and Vice-Dean of the UC-Davis Medical School, for a five minute discussion about an important recent POEM. The discussion provides additional depth and insight into the issue covered by the POEM synopsis.

Episode 559: SGLT-2 inhibitors or GLP-1 receptor agonists reduce cardiovascular outcomes in patients with type 2 diabetes

Dr. Ebell and Dr. Wilkes discuss the POEM titled ' SGLT-2 inhibitors or GLP-1 receptor agonists reduce cardiovascular outcomes in patients with type 2 diabetes '

Download Episode 559 (mp3, 7.2MB)

Read the Related POEM synopsis (COVID-19 POEMs are freely accessible to all. All non COVID-19 POEMs will require an Essential Evidence Plus subscription)

POEM of the Week Podcast Archive